Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028247
Filing Date
2024-12-04
Accepted
2024-12-04 16:17:28
Documents
2
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 form4-12042024_091224.html 4  
1 form4-12042024_091224.xml 4 3695
2 ex24-12042024_091224.htm EX-24 3879
  Complete submission text file 0001415889-24-028247.txt   8966
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address
Hemrajani Rekha (Reporting) CIK: 0001771213 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39386 | Film No.: 241526412

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)